Cargando…
Clinical Trials and Tribulations in the COVID-19 Era
Advances in treating and preventing Alzheimer disease and other neurocognitive disorders of aging arise from rigorous preclinical and clinical research, with randomized controlled treatment trials as the last and definitive test. The COVID-19 pandemic has greatly disrupted ongoing interventional stu...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Association for Geriatric Psychiatry. Published by Elsevier Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236727/ https://www.ncbi.nlm.nih.gov/pubmed/32507686 http://dx.doi.org/10.1016/j.jagp.2020.05.016 |